Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 8:57 pm Purchase | 2025-06-30 | 13G | BIO-key International, Inc. BKYI | ARMISTICE CAPITAL LLC | 359,703 4.990% | 359,703 (New Position) | Filing History |
| 2025-08-14 4:45 pm Sale | 2025-06-30 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,860,317 3.900% | -1,879,001 (-50.25%) | Filing History |
| 2025-08-14 08:45 am Sale | 2025-06-30 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 1,203,244 2.420% | -1,617,927 (-57.35%) | Filing History |
| 2025-05-15 4:34 pm Sale | 2025-03-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 3,739,318 7.800% | -490,984 (-11.61%) | Filing History |
| 2025-05-15 3:08 pm Purchase | 2025-03-31 | 13G | Bicycle Therapeutics plc BCYC | ARMISTICE CAPITAL LLC | 2,672,000 5.590% | 2,672,000 (New Position) | Filing History |
| 2025-05-15 08:37 am Sale | 2025-03-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 2,821,171 5.670% | -509,065 (-15.29%) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 3,330,236 6.710% | -160,270 (-4.59%) | Filing History |
| 2025-02-11 09:09 am Purchase | 2024-12-31 | 13G | Bicycle Therapeutics plc BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 2,610,337 5.490% | 2,610,337 (New Position) | Filing History |
| 2024-12-20 4:05 pm Purchase | 2024-12-13 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 4,230,302 8.900% | 3,209,134 (+314.26%) | Filing History |
| 2024-12-19 3:47 pm Purchase | 2024-11-21 | 13G | Bicycle Therapeutics plc BCYC | Forbion Growth Opportunities Fund II Cooperatief U.A. | 3,452,330 7.300% | 3,452,330 (New Position) | Filing History |
| 2024-12-17 6:46 pm Purchase | 2024-12-13 | 13D | Bicycle Therapeutics plc BCYC | Baker Bros. Advisors LP | 10,885,357 22.900% | 1,485,397 (+15.80%) | Filing History |
| 2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | RA Capital Management, L.P. | 2,253,000 4.700% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | Paradigm Biocapital Advisors LP | 0 0.000% | -3,707,001 (Position Closed) | Filing History |
| 2024-11-13 9:30 pm Sale | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | Jefferies Financial Group Inc. JEF | 0 0.000% | -1,948,000 (Position Closed) | Filing History |
| 2024-06-07 4:18 pm Purchase | 2024-05-28 | 13G | Bicycle Therapeutics plc BCYC | RA Capital Management, L.P. | 2,253,000 5.000% | 2,253,000 (New Position) | Filing History |
| 2024-05-28 4:16 pm Purchase | 2024-05-23 | 13D | Bicycle Therapeutics plc BCYC | Baker Bros. Advisors LP | 9,399,960 19.900% | 1,710,717 (+22.25%) | Filing History |
| 2024-04-18 07:29 am Purchase | 2024-04-16 | 13D | Bicycle Therapeutics plc BCYC | Baker Bros. Advisors LP | 7,689,243 19.900% | 2,865,645 (+59.41%) | Filing History |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 844,235 2.200% | -1,420,566 (-62.72%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | Paradigm Biocapital Advisors LP | 3,707,001 9.800% | 2,096,336 (+130.15%) | Filing History |
| 2024-02-14 4:07 pm Purchase | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | Jefferies Financial Group Inc. JEF | 1,948,000 5.165% | 1,948,000 (New Position) | Filing History |